Stock Information
Zevra Therapeutics Inc (ZVRA)
Ticker Symbol: ZVRA
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $574.79 mil
Piotroski score: 7
PE Ratio: 8.1229
EPS (TTM): 1.4666
Revenue (TTM): $1.81 M
Dividend Yield: N/A%
ROE: 74.63%
Latest News
-
Guggenheim Maintains Buy on Zevra Therapeutics, Raises Price Target to $25
Fri, May 8, 2026 9:29 AM
-
Zevra Therapeutics, Inc. (ZVRA) Q1 2026 Earnings Call Transcript
Thu, May 7, 2026 12:21 AM
-
Transcript : Zevra Therapeutics, Inc., Q1 2026 Earnings Call, May 06, 2026
Thu, May 7, 2026 12:05 AM
-
Zevra Therapeutics (NASDAQ:ZVRA) Shares Surge After Blowout Q1 Earnings Beat
Wed, May 6, 2026 9:08 PM
-
CORRECTION: Zevra Therapeutics Q1 Adj. EPS $0.18 Beats $0.08 Estimate, Sales $36.220M Beat $31.960M Estimate
Wed, May 6, 2026 5:23 PM
-
Earnings Scheduled For May 6, 2026
Wed, May 6, 2026 5:03 PM
-
Zevra Therapeutics: Q1 Earnings Snapshot
Wed, May 6, 2026 4:53 PM
Key Financials
Financial data not available
